Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository

Part of paid clinical trials in New York, New York.

Sponsor
Weill Medical College of Cornell University
Study ID
NCT03901521
Status
Enrolling By Invitation

Conditions

  • Autosomal Dominant Polycystic Kidney Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Study Details

This study will analyze the germline and somatic mutations underlying the development of ADPKD in order to better understand the genetic mechanism responsible for the cystic transformation. Once identified, these mutations could help us understand better the mechanism leading to the development of this disease and may explain at least in part the phenotypic variability.

Key Dates

Start date
Jun 1, 2018
Status verified
Jan 2026
Primary completion
Dec 31, 2028
Completion
Dec 31, 2028

Study Design

Enrollment
100 participants (estimated)

Primary Outcome Measure

The presence of somatic PKD 1/2 gene mutations in cyst epithelial cells [ Time Frame: 10 YEARS ]

Locations (1)

FacilityCityStateZIPSite coordinators
Weill Cornell MedicineNew YorkNew York10021-

Find similar trials in New York, NY

By research site
Weill Cornell Medicine· New York, NY

Related Studies